SamRx selects Vercara UltraPlatform for Endpoint Detection and Response (EDR)
In 2024, SamRx, a United States based Life Sciences organization with 20 employees and revenues of $2M selected Vercara UltraPlatform for Endpoint Detection and Response (EDR) while displacing Legacy, and integrating with the existing systems being used.
| Customer | Vendor | Old Product | New Product | Category | Market | Users | VAR/SI | When | Live | SamRx | Vercara | Legacy | Vercara UltraPlatform | Endpoint Detection and Response (EDR) | CyberSecurity | n/a | n/a | 2024 | 2024 |
|---|